210 related articles for article (PubMed ID: 28407685)
1. Extra-pancreatic invasion induces lipolytic and fibrotic changes in the adipose microenvironment, with released fatty acids enhancing the invasiveness of pancreatic cancer cells.
Okumura T; Ohuchida K; Sada M; Abe T; Endo S; Koikawa K; Iwamoto C; Miura D; Mizuuchi Y; Moriyama T; Nakata K; Miyasaka Y; Manabe T; Ohtsuka T; Nagai E; Mizumoto K; Oda Y; Hashizume M; Nakamura M
Oncotarget; 2017 Mar; 8(11):18280-18295. PubMed ID: 28407685
[TBL] [Abstract][Full Text] [Related]
2. Tumoral acidosis promotes adipose tissue depletion by fostering adipocyte lipolysis.
Lefevre C; Thibaut MM; Loumaye A; Thissen JP; Neyrinck AM; Navez B; Delzenne NM; Feron O; Bindels LB
Mol Metab; 2024 May; 83():101930. PubMed ID: 38570069
[TBL] [Abstract][Full Text] [Related]
3. Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice.
Peran I; Dakshanamurthy S; McCoy MD; Mavropoulos A; Allo B; Sebastian A; Hum NR; Sprague SC; Martin KA; Pishvaian MJ; Vietsch EE; Wellstein A; Atkins MB; Weiner LM; Quong AA; Loots GG; Yoo SS; Assefnia S; Byers SW
Gastroenterology; 2021 Mar; 160(4):1359-1372.e13. PubMed ID: 33307028
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine enhances cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling.
Xu BQ; Fu ZG; Meng Y; Wu XQ; Wu B; Xu L; Jiang JL; Li L; Chen ZN
Oncotarget; 2016 Sep; 7(38):62177-62193. PubMed ID: 27556697
[TBL] [Abstract][Full Text] [Related]
5. Administration of Gemcitabine After Pancreatic Tumor Resection in Mice Induces an Antitumor Immune Response Mediated by Natural Killer Cells.
Gürlevik E; Fleischmann-Mundt B; Brooks J; Demir IE; Steiger K; Ribback S; Yevsa T; Woller N; Kloos A; Ostroumov D; Armbrecht N; Manns MP; Dombrowski F; Saborowski M; Kleine M; Wirth TC; Oettle H; Ceyhan GO; Esposito I; Calvisi DF; Kubicka S; Kühnel F
Gastroenterology; 2016 Aug; 151(2):338-350.e7. PubMed ID: 27210037
[TBL] [Abstract][Full Text] [Related]
6. LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis.
Melisi D; Ishiyama S; Sclabas GM; Fleming JB; Xia Q; Tortora G; Abbruzzese JL; Chiao PJ
Mol Cancer Ther; 2008 Apr; 7(4):829-40. PubMed ID: 18413796
[TBL] [Abstract][Full Text] [Related]
7. Adipose tissue-derived stromal cells are sources of cancer-associated fibroblasts and enhance tumor progression by dense collagen matrix.
Okumura T; Ohuchida K; Kibe S; Iwamoto C; Ando Y; Takesue S; Nakayama H; Abe T; Endo S; Koikawa K; Sada M; Horioka K; Mochidome N; Arita M; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Mizumoto K; Oda Y; Hashizume M; Nakamura M
Int J Cancer; 2019 Mar; 144(6):1401-1413. PubMed ID: 30152542
[TBL] [Abstract][Full Text] [Related]
8. Fatty acids from fat cell lipolysis do not activate an inflammatory response but are stored as triacylglycerols in adipose tissue macrophages.
Caspar-Bauguil S; Kolditz CI; Lefort C; Vila I; Mouisel E; Beuzelin D; Tavernier G; Marques MA; Zakaroff-Girard A; Pecher C; Houssier M; Mir L; Nicolas S; Moro C; Langin D
Diabetologia; 2015 Nov; 58(11):2627-36. PubMed ID: 26245186
[TBL] [Abstract][Full Text] [Related]
9. Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice.
Grippo PJ; Fitchev PS; Bentrem DJ; Melstrom LG; Dangi-Garimella S; Krantz SB; Heiferman MJ; Chung C; Adrian K; Cornwell ML; Flesche JB; Rao SM; Talamonti MS; Munshi HG; Crawford SE
Gut; 2012 Oct; 61(10):1454-64. PubMed ID: 22234980
[TBL] [Abstract][Full Text] [Related]
10. Defective adipose lipolysis and altered global energy metabolism in mice with adipose overexpression of the lipolytic inhibitor G0/G1 switch gene 2 (G0S2).
Heckmann BL; Zhang X; Xie X; Saarinen A; Lu X; Yang X; Liu J
J Biol Chem; 2014 Jan; 289(4):1905-16. PubMed ID: 24302733
[TBL] [Abstract][Full Text] [Related]
11. Modifications induced by dietary lipid source in adipose tissue phospholipid fatty acids and their consequences in lipid mobilization.
Portillo MP; Tueros AI; Perona JS; Ruiz-Gutiérrez V; Torres I; Macarulla MT
Br J Nutr; 1999 Oct; 82(4):319-27. PubMed ID: 10655981
[TBL] [Abstract][Full Text] [Related]
12. Effects of ER-resident and secreted AGR2 on cell proliferation, migration, invasion, and survival in PANC-1 pancreatic cancer cells.
Hong X; Li ZX; Hou J; Zhang HY; Zhang CY; Zhang J; Sun H; Pang LH; Wang T; Deng ZH
BMC Cancer; 2021 Jan; 21(1):33. PubMed ID: 33413231
[TBL] [Abstract][Full Text] [Related]
13. The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer.
Pan MR; Hsu MC; Luo CW; Chen LT; Shan YS; Hung WC
Oncotarget; 2016 Sep; 7(38):61136-61151. PubMed ID: 27531902
[TBL] [Abstract][Full Text] [Related]
14. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
Zhu H; Gao W; Li X; Yu L; Luo D; Liu Y; Yu X
Pancreatology; 2021 Apr; 21(3):589-598. PubMed ID: 33579599
[TBL] [Abstract][Full Text] [Related]
15. Targeting pancreatic cancer using a combination of gemcitabine with the omega-3 polyunsaturated fatty acid emulsion, Lipidem™.
Haqq J; Howells LM; Garcea G; Dennison AR
Mol Nutr Food Res; 2016 Jun; 60(6):1437-47. PubMed ID: 26603273
[TBL] [Abstract][Full Text] [Related]
16. Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells.
Matsuzawa F; Kamachi H; Mizukami T; Einama T; Kawamata F; Fujii Y; Fukai M; Kobayashi N; Hatanaka Y; Taketomi A
BMC Cancer; 2021 Feb; 21(1):200. PubMed ID: 33637083
[TBL] [Abstract][Full Text] [Related]
17. Bmi1 enhances tumorigenicity and cancer stem cell function in pancreatic adenocarcinoma.
Proctor E; Waghray M; Lee CJ; Heidt DG; Yalamanchili M; Li C; Bednar F; Simeone DM
PLoS One; 2013; 8(2):e55820. PubMed ID: 23437065
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.
Zheng X; Carstens JL; Kim J; Scheible M; Kaye J; Sugimoto H; Wu CC; LeBleu VS; Kalluri R
Nature; 2015 Nov; 527(7579):525-530. PubMed ID: 26560028
[TBL] [Abstract][Full Text] [Related]
19. Suppression of STAT5b in pancreatic cancer cells leads to attenuated gemcitabine chemoresistance, adhesion and invasion.
Sumiyoshi H; Matsushita A; Nakamura Y; Matsuda Y; Ishiwata T; Naito Z; Uchida E
Oncol Rep; 2016 Jun; 35(6):3216-26. PubMed ID: 27035235
[TBL] [Abstract][Full Text] [Related]
20. Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells.
Kozono S; Ohuchida K; Eguchi D; Ikenaga N; Fujiwara K; Cui L; Mizumoto K; Tanaka M
Cancer Res; 2013 Apr; 73(7):2345-56. PubMed ID: 23348422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
